Longevity News
The latest longevity research, curated from leading sources and analyzed through the EDGE Framework.
The latest longevity research, curated from leading sources and analyzed through the EDGE Framework.
Omega-3 polyunsaturated fatty acids reduce cellular senescence in kidney tissue through FFAR4 activation, restoring filtration function and reducing fibrosis in aged mice and disease models. This mechanism explains previously mixed clinical findings and identifies a specific pathway relevant to chronic kidney disease progression.
Sunrise Air, an FDA-cleared rechargeable home sleep testing device, enables multi-night monitoring of sleep apnea using a minimalist chin sensor rather than traditional clinic-based polysomnography. This approach addresses both the practical barriers to diagnosis and the physiological reality that sleep patterns vary significantly night-to-night, making single-night clinical studies insufficient for accurate apnea detection.
LifespanningRx's partnership with RegenTherapy expands access to regenerative longevity programs by integrating cellular recovery technologies into a consumer-friendly telehealth platform. The collaboration reflects a shift in regenerative medicine from elite-only treatments toward mainstream accessibility, positioning cellular signaling support as infrastructure for sustained functional health rather than life extension.
Mabwell's 9MW2821, a Nectin-4-targeting antibody-drug conjugate, demonstrated an 83% objective response rate in combination with toripalimab for locally advanced or metastatic urothelial carcinoma, with a confirmed response rate of 74.5% and median progression-free survival of 12.9 months. Early-stage perioperative data in muscle-invasive bladder cancer showed a 66.7% pathological complete response rate with acceptable tolerability, positioning this agent as a multi-indication candidate in genitourinary and gynecologic malignancies.
ProHealth introduced Essentials NMN 500, a 500 mg nicotinamide mononucleotide supplement using an amorphous formulation claimed to enhance bioavailability, priced at $24.95 for 30 capsules. Published research supports that NMN supplementation raises blood NAD+ levels within the 250-1,200 mg dose range, though direct clinical comparison data between formulation types remains limited.
Time-restricted feeding enhances the regenerative capacity of adipose-derived stem cells through activation of specific transcriptional programs associated with cellular reprogramming factors. This finding suggests that temporal eating patterns influence stem cell function at the molecular level, with implications for tissue repair and longevity-related regenerative capacity.
Omega-3 polyunsaturated fatty acids reduce kidney aging and fibrosis through a receptor called FFAR4, which activates cellular regeneration pathways in tubular cells. FFAR4 expression declines with age and in chronic kidney disease patients, and restoring its signaling mitigates senescence and fibrotic progression.
Self-collected HPV testing at home increases screening adherence by removing barriers to access and discomfort, shifting cervical cancer prevention from clinician-dependent protocols to patient-initiated surveillance. This decentralization of screening addresses a persistent gap in prevention coverage among women who avoid or delay traditional Pap smears.
Osteocalcin, a bone-derived hormone, activates protective mechanisms in the nervous system when estrogen declines following ovariectomy in mice. This finding identifies a compensatory endocrine pathway that may explain neurological resilience during menopause and suggests osteocalcin as a therapeutic target for estrogen-deficiency-related cognitive decline.
Oligomerix completed a Phase 1a trial of OLX-07010, an oral tau-targeting therapy showing favorable safety and appropriate drug exposure in healthy volunteers. The compound represents a shift toward preventive approaches in neurodegeneration by inhibiting tau protein misfolding rather than clearing existing damage.
China has launched a structured, national physician training program in longevity medicine designed to embed preventive healthspan protocols into mainstream clinical practice across internal medicine, geriatrics, cardiology, and endocrinology. This represents a systemic shift from reactive disease management to prospective health optimization at the healthcare infrastructure level, positioning longevity medicine as an institutional and economic necessity rather than a niche practice.
Phosphatidylcholine, the dominant lipid in mitochondrial membranes, declines with age and drives mitochondrial fragmentation and dysfunction. The decline occurs through reduced activity of S-adenosylmethionine synthetase (SAMS-1), a protein that coordinates phosphatidylcholine synthesis. This pathway represents a modifiable driver of mitochondrial aging with potential intervention points in later life.